Product News

UPM Raflatac – New materials for pharmaceutical labelling

Good label hold on small diameters

FINLAND • UPM Raflatac has launched a range of pharmaceutical labelling materials which support compliance with the Falsified Medicines Directive (2011/62/EU) regarding packaging for prescription drugs and high-risk, over-the-counter medicines.

The new RP 62 EU and RP 62 EUL adhesives combined with transparent filmic label faces offers pharmaceutical manufacturers the required tamper-evidence, with no need to change the existing graphic design of their packages. The RP 31 Purus adhesive minimizes migration risk in medical, pharmaceutical and healthcare applications. RP 31 Purus label stocks are pharmaceutically compliant and also provide good mandrel hold on small diameters. The company’s label stocks featuring the RP Cryo adhesive withstand direct, long-term immersion in liquid nitrogen in temperatures as low as -196 °C. Good printability with thermal transfer enables automated sample management and helps eliminate the possibility of human error when marking by hand.

Armin Karl Geiger

Your Opinion